<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6200819</article-id><article-id pub-id-type="publisher-id">34054</article-id><article-id pub-id-type="doi">10.1038/s41598-018-34054-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The roles of IL-17C in T cell-dependent and -independent inflammatory diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Sachiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2797-6420</contrib-id><name><surname>Nambu</surname><given-names>Aya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Numata</surname><given-names>Takafumi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yoshizaki</surname><given-names>Takamichi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Narushima</surname><given-names>Seiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shimura</surname><given-names>Eri</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hiraishi</surname><given-names>Yoshihisa</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arae</surname><given-names>Ken</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Morita</surname><given-names>Hideaki</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Hisatome</surname><given-names>Ichiro</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Sudo</surname><given-names>Katsuko</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nakae</surname><given-names>Susumu</given-names></name><address><email>snakae@ims.u-tokyo.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution>Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, 108-8639 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0663 3325</institution-id><institution-id institution-id-type="GRID">grid.410793.8</institution-id><institution>Department of Dermatology, </institution><institution>Tokyo Medical University, </institution></institution-wrap>Tokyo, 160-0023 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000123090000</institution-id><institution-id institution-id-type="GRID">grid.410804.9</institution-id><institution>Department of Cardiovascular Surgery, Saitama Medical Center, </institution><institution>Jichi Medical University, </institution></institution-wrap>Saitama, 330-8503 Japan </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 2738</institution-id><institution-id institution-id-type="GRID">grid.258269.2</institution-id><institution>Department of Chemistry, </institution><institution>Juntendo University School of Medicine, </institution></institution-wrap>Chiba, 270-1695 Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9340 2869</institution-id><institution-id institution-id-type="GRID">grid.411205.3</institution-id><institution>Department of Immunology, Faculty of Health Sciences, </institution><institution>Kyorin University, </institution></institution-wrap>Tokyo, 181-8612 Japan </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0377 2305</institution-id><institution-id institution-id-type="GRID">grid.63906.3a</institution-id><institution>Department of Allergy and Clinical Immunology, </institution><institution>National Research Institute for Child Health and Development, </institution></institution-wrap>Tokyo, 157-8535 Japan </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0663 5064</institution-id><institution-id institution-id-type="GRID">grid.265107.7</institution-id><institution>Division of Regenerative Medicine and Therapeutics, </institution><institution>Tottori University Graduate School of Medical Science, </institution></institution-wrap>Yonago, 683-8503 Japan </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0663 3325</institution-id><institution-id institution-id-type="GRID">grid.410793.8</institution-id><institution>Animal Research Center, </institution><institution>Tokyo Medical University, </institution></institution-wrap>Tokyo, 160-8402 Japan </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1754 9200</institution-id><institution-id institution-id-type="GRID">grid.419082.6</institution-id><institution>Precursory Research for Embryonic Science and Technology, </institution><institution>Japan Science and Technology Agency, </institution></institution-wrap>Saitama, 332-0012 Japan </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>8</volume><elocation-id>15750</elocation-id><history><date date-type="received"><day>16</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">IL-17C, which is a member of the IL-17 family of cytokines, is preferentially produced by epithelial cells in the lung, skin and colon, suggesting that IL-17C may be involved in not only host defense but also inflammatory diseases in those tissues. In support of that, IL-17C was demonstrated to contribute to development of T cell-dependent imiquimod-induced psoriatic dermatitis and T cell-independent dextran sodium sulfate-induced acute colitis using mice deficient in IL-17C and/or IL-17RE, which is a component of the receptor for IL-17C. However, the roles of IL-17C in other inflammatory diseases remain poorly understood. Therefore, we investigated the contributions of IL-17C to development of certain disease models using <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice, which we newly generated. Those mice showed normal development of T cell-dependent inflammatory diseases such as FITC- and DNFB-induced contact dermatitis/contact hypersensitivity (CHS) and concanavalin A-induced hepatitis, and T cell-independent inflammatory diseases such as bleomycin-induced pulmonary fibrosis, papain-induced airway eosinophilia and LPS-induced airway neutrophilia. On the other hand, those mice were highly resistant to LPS-induced endotoxin shock, indicating that IL-17C is crucial for protection against that immunological reaction. Therefore, IL-17C neutralization may represent a novel therapeutic approach for sepsis, in addition to psoriasis and acute colitis.</p></abstract><funding-group><award-group><funding-source><institution>Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, and Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">IL-17C is a member of the IL-17 family of cytokines that includes IL-17A, IL-17B, IL-17D, IL-17E/IL-25 and IL-17F. It was originally identified as an IL-17-related cytokine by using EST databases<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. It is well known that IL-17A and IL-17F are preferentially produced by immune cells such as T cells and group 3 innate lymphoid cells, while IL-17C and IL-25 are predominantly produced by non-immune cells such as colonic and lung epithelial cells<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref></sup>, keratinocytes<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup> and smooth muscle cells<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, in mice and/or humans.</p><p id="Par3">IL-17C is known to be important for host defense against such pathogens as <italic>Pseudomonas aeruginosa</italic><sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. On the other hand, inappropriate/excessive IL-17C expression may be involved in development or regulation of various disorders in mice and/or humans. <italic>Il17c</italic> mRNA was reported to be increased in the inflamed skin from patients with psoriasis<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup> and in anti-TNF-induced psoriasiform skin lesions of patients with Crohn&#x02019;s disease<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. The mRNA for this cytokine is also increased in synovial fluid mononuclear cells from patients with rheumatoid arthritis<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, and overexpression of IL-17C in mice resulted in exacerbation of collagen-induced arthritis<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. SNPs in <italic>Il17re</italic> genes, which are components of the receptor for IL-17C<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>, were associated with risk for susceptibility to ulcerative colitis in Germany<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. On the other hand, mice deficient in <italic>Il17c</italic> and <italic>Il17re</italic> showed aggravated inflammation during dextran sodium sulfate-induced colitis<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, suggesting that IL-17C plays a regulatory role in the setting. Moreover, IL-17C may be involved in development of COPD<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, cystic fibrosis<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and atherosclerosis<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. IL-17C is also thought to be involved in tumorigenesis: increased expression of <italic>Il17c</italic> mRNA and IL-17RE protein was observed in lung cancer and hepatocellular carcinoma, respectively<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, and tumor growth was reduced in <italic>Il17c</italic>-deficient (<italic>Il17</italic>c<sup>&#x02212;/&#x02212;</sup>) mice after non-typeable <italic>Haemophilus influenza</italic> infection<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and in <italic>Il17re</italic><sup>&#x02212;/&#x02212;</sup> mice on the <italic>Apc</italic><sup>min/+</sup> background<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. IL-17C can enhance IL-17A production by Th17 cells, contributing to development of Th17 cell-mediated autoimmune diseases such as experimental autoimmune encephalomyelitis<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par4">In the present study, we investigated the roles of IL-17C in T cell-dependent diseases such as contact dermatitis and hepatitis, T cell-independent diseases such as pulmonary fibrosis and inflammation, and endotoxin shock using <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice, which we newly generated.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Generation of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice</title><p id="Par5"><italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice were generated from C57BL/6N wild-type mice by replacing the <italic>Il17c</italic> genes with the neomycin resistance gene, flanked by <italic>loxP</italic> sequences in C57BL/6 mouse-derived ES cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice were born under specific-pathogen-free housing conditions at the expected Mendelian ratio, fertile, and did not show any gross phenotypic abnormalities (data not shown). Expression of <italic>Il17c</italic> mRNA was detected in various tissues from wild-type mice by quantitative PCR, whereas it was below the limit of detection in tissues from the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). No apparent abnormalities were found in the proportions of immune cells in the thymus, LNs, spleen and/or bone marrow between the wild-type and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (data not shown).<fig id="Fig1"><label>Figure 1</label><caption><p>Generation of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>a</bold>) IL-17C gene targeting strategy. The region of the <italic>Il17c</italic> gene containing from exon 1 to exon 3 was replaced with a cassette containing a neomycin resistance gene (<italic>Neo</italic><sup>r</sup>), flanked by <italic>loxP</italic> sequences. (<bold>b</bold>) Expression of <italic>Il17c</italic> mRNA in various tissues from wild-type (n&#x02009;=&#x02009;3) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> (n&#x02009;=&#x02009;3) mice, determined by qPCR. The data show the mean&#x02009;+&#x02009;SEM.</p></caption><graphic xlink:href="41598_2018_34054_Fig1_HTML" id="d29e641"/></fig></p></sec><sec id="Sec4"><title>IL-17C is not essential for development of T cell-dependent contact dermatitis</title><p id="Par6">It is known that hapten-induced contact dermatitis/contact hypersensitivity (CHS) is mediated by hapten-specific Th cells<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. We found that the thickness of ear skin and severity of skin inflammation (based on histological analysis) were comparable between the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice and wild-type mice during FITC- and DNFB-induced CHS (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a&#x02013;c</xref>). However, mRNA expression for <italic>Il17c</italic> was increased in the ear skin from the wild-type mice, but not the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice, after FITC and DNFB challenge (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a,b</xref>). In addition, mRNA expression for <italic>Tnfa</italic> and <italic>Ccl11</italic> in the skin after FITC challenge and mRNA expression for <italic>Ifng</italic> and <italic>Il6</italic> in the skin after DNFB challenge were reduced in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice compared with the wild-type mice (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a,b</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>Normal development of T cell-dependent contact dermatitis in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>a</bold>) Wild-type (n&#x02009;=&#x02009;18) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> (n&#x02009;=&#x02009;17) mice were epicutaneously sensitized and challenged with FITC or vehicle alone. The ear skin thickness of the mice was measured at the indicated time points after challenge. (<bold>b</bold>) Wild-type (n&#x02009;=&#x02009;15) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> (n&#x02009;=&#x02009;17) mice were epicutaneously sensitized and challenged with DNFB or vehicle alone. The ear skin thickness of the mice was measured at the indicated time points after challenge. (<bold>c</bold>) Representative images of skin sections (from 24&#x02009;hours in (<bold>a</bold>) and (<bold>b</bold>)) stained with hematoxylin and eosin. &#x000d7;100. The data show the mean&#x02009;+&#x02009;SEM (<bold>a</bold> and <bold>b</bold>).</p></caption><graphic xlink:href="41598_2018_34054_Fig2_HTML" id="d29e738"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>Gene expression in the skin, and Ab production in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>a</bold>) Relative mRNA expression levels of cytokines and chemokines in the ear skin of wild-type and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice 24&#x02009;hours after FITC challenge. V&#x02009;=&#x02009;vehicle treatment. Wild-type mice (vehicle, n&#x02009;=&#x02009;3; FITC, n&#x02009;=&#x02009;5) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (vehicle, n&#x02009;=&#x02009;3; FITC, n&#x02009;=&#x02009;6). (<bold>b</bold>) Relative mRNA expression levels of cytokines and chemokines in the ear skin of wild-type and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice 24&#x02009;hours after DNFB challenge. V&#x02009;=&#x02009;vehicle treatment. Wild-type mice (vehicle, n&#x02009;=&#x02009;3; FITC, n&#x02009;=&#x02009;5) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (vehicle, n&#x02009;=&#x02009;3; FITC, n&#x02009;=&#x02009;5). (<bold>c</bold>) Sera were collected from mice 72&#x02009;hours after FITC challenge. The levels of FITC-specific Ig subsets in sera were determined by ELISA. N&#x02009;=&#x02009;na&#x000ef;ve. Wild-type mice (naive, n&#x02009;=&#x02009;8; FITC, n&#x02009;=&#x02009;30) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (naive, n&#x02009;=&#x02009;4; FITC, n&#x02009;=&#x02009;32). (<bold>d</bold>) Sera were collected from mice 72&#x02009;hours after DNFB challenge. The levels of DNP-specific Ig subsets in sera were determined by ELISA. N&#x02009;=&#x02009;na&#x000ef;ve. Wild-type mice (naive, n&#x02009;=&#x02009;8; DNFB, n&#x02009;=&#x02009;27) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (naive, n&#x02009;=&#x02009;5; DNFB, n&#x02009;=&#x02009;30). The data show the mean&#x02009;+&#x02009;SEM. *p&#x02009;&#x0003c;&#x02009;0.05, **p&#x02009;&#x0003c;&#x02009;0.01 and ***p&#x02009;&#x0003c;&#x02009;0.001: vehicle vs FITC or DNFB; and <sup>&#x02020;</sup>p&#x02009;&#x0003c;&#x02009;0.05 and <sup>&#x02020;&#x02020;</sup>p&#x02009;&#x0003c;&#x02009;0.01: wild-type mice vs. <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. Analyses by Mann-Whitney U-test, two-tailed (<bold>a</bold>, <bold>b</bold>) and Student&#x02019;s t-test, two-tailed (<bold>c</bold>, <bold>d</bold>). NS&#x02009;=&#x02009;not significant.</p></caption><graphic xlink:href="41598_2018_34054_Fig3_HTML" id="d29e820"/></fig></p><p id="Par7">The levels of FITC-specific Ig subsets in sera were comparable between the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice during FITC-induced CHS (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>), whereas the levels of DNP-specific IgG1 and IgG2a, but not IgG3, in sera were significantly reduced in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice compared with the wild-type mice during DNFB-induced CHS (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). These observations suggest that IL-17c is at least partially involved in such immune responses as mRNA expression and Ab production, but is not essential for development of CHS induced by FITC or DNFB.</p></sec><sec id="Sec5"><title>IL-17C is not required for development of T cell-mediated hepatitis</title><p id="Par8">It is known that Con A-induced hepatitis is accompanied by apoptosis in tissues via Fas on T cells<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. After Con A injection, the levels of GOT and GPT activities in sera were comparable in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>). In addition, infiltration of PMNs into the liver was also similarly observed in both groups (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). These observations suggest that IL-17C is not essential for T cell-mediated tissue injury in Con A-induced hepatitis.<fig id="Fig4"><label>Figure 4</label><caption><p>Normal development of T cell-dependent hepatitis in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. Female mice were injected intravenously with concanavalin A (Con A). 24&#x02009;hours later, sera and livers were collected. (<bold>a</bold>) Serum levels of GOT and GPT. Wild-type mice (Saline, n&#x02009;=&#x02009;4; Con A, n&#x02009;=&#x02009;5) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (Saline, n&#x02009;=&#x02009;3; Con A, n&#x02009;=&#x02009;5). The data show the mean&#x02009;+&#x02009;SEM. NS&#x02009;=&#x02009;not significant. (<bold>b</bold>) Representative images of liver sections stained with hematoxylin and eosin. Bars&#x02009;=&#x02009;20&#x02009;&#x003bc;m.</p></caption><graphic xlink:href="41598_2018_34054_Fig4_HTML" id="d29e883"/></fig></p></sec><sec id="Sec6"><title>IL-17C is crucial for suppression of T cell-independent acute colitis</title><p id="Par9">Dextran sodium sulfate (DSS)-induced acute colitis developed even in mice lacking T cells<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. It was already demonstrated that <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice and <italic>Il17re</italic><sup>&#x02212;/&#x02212;</sup> mice showed aggravated development of T cell-independent DSS-induced acute colitis<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. We confirmed that body weight loss was more severe in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice than in the wild-type mice after drinking of water containing DSS (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a,b</xref>). The length of the colon in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice was significantly shortened compared with wild-type mice on Day 8 during DSS-induced colitis (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5c,d</xref>). Histological analysis revealed that local inflammation in the colon was more severe in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice than in the wild-type mice on Day 8 during DSS-induced colitis (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5e,f</xref>). These observations indicate that IL-17C is crucial for suppression of DSS-induced acute colitis.<fig id="Fig5"><label>Figure 5</label><caption><p>High susceptibility of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice to T cell-independent DSS-induced colitis. Female mice were provided sterile drinking water containing 2.0% DSS ad libitum for 5 days, followed by 15 days of regular drinking water. (<bold>a</bold>) Change in body weight (%). Wild-type mice (n&#x02009;=&#x02009;10) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (n&#x02009;=&#x02009;10). *p&#x02009;&#x0003c;&#x02009;0.05 and **p&#x02009;&#x0003c;&#x02009;0.01 vs. corresponding values for <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>b</bold>) Area under the curve (AUC) for the body weight on Days 5&#x02013;8 in (<bold>a</bold>). **p&#x02009;&#x0003c;&#x02009;0.01. (<bold>c</bold>)Representative pictures of the animals&#x02019; colons on Day 8. (<bold>d</bold>) Length of colons on the indicated days. Wild-type mice (na&#x000ef;ve, n&#x02009;=&#x02009;4; and Days 8, 15, and 33, n&#x02009;=&#x02009;4&#x02013;5) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (na&#x000ef;ve, n&#x02009;=&#x02009;4; and Days 8, 15, and 33, n&#x02009;=&#x02009;8&#x02013;10). (<bold>e</bold>) Representative images of colon sections (Day 8) stained with hematoxylin and eosin. Bars&#x02009;=&#x02009;100&#x02009;&#x003bc;m. (<bold>f</bold>) Histological scores on Day 8. **p&#x02009;&#x0003c;&#x02009;0.01. The data show the mean&#x02009;+&#x02009;SEM (<bold>a</bold>,<bold>b</bold>,<bold>d</bold>,<bold>f</bold>).</p></caption><graphic xlink:href="41598_2018_34054_Fig5_HTML" id="d29e1002"/></fig></p></sec><sec id="Sec7"><title>IL-17C is not essential for development of T cell-independent lung diseases</title><p id="Par10">Constitutive expression of <italic>Il17c</italic> mRNA was observed in the lungs from wild-type mice, but not <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>), suggesting that IL-17C may be involved in lung disease. Therefore, we investigated the role of IL-17C in bleomycin-induced pulmonary fibrosis, which develops independently of T cells<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. However, the numbers of eosinophils, neutrophils, macrophages and lymphocytes in BAL fluids were comparable in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice 14 days after intratracheal bleomycin challenge (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>). Inflammation and fibrosis based on histological analysis (HE and EVG staining, respectively) were also comparable in the lungs of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice during bleomycin-induced pulmonary fibrosis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6b,c</xref>), indicating that IL-17C is not essential for development of bleomycin-induced pulmonary fibrosis.<fig id="Fig6"><label>Figure 6</label><caption><p>Normal development of T cell-independent pulmonary fibrosis in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. Male mice were treated intratracheally with bleomycin (BLM) or PBS. 14 days later, bronchoalveolar lavage (BAL) fluids and the lungs were collected. (<bold>a</bold>) Cell counts in BAL fluids. Wild-type mice (PBS, n&#x02009;=&#x02009;5; BLM, n&#x02009;=&#x02009;9) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (PBS, n&#x02009;=&#x02009;5; BLM, n&#x02009;=&#x02009;7). The data show the mean&#x02009;+&#x02009;SEM. **p&#x02009;&#x0003c;&#x02009;0.01 and ***p&#x02009;&#x0003c;&#x02009;0.001: PBS vs BLM; and <sup>&#x02020;</sup>p&#x02009;&#x0003c;&#x02009;0.05: wild-type mice vs. <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>b</bold>,<bold>c</bold>) Representative images of lung sections. Hematoxylin and eosin staining (<bold>b</bold>) and Elastica van Gieson staining (<bold>c</bold>). Bars&#x02009;=&#x02009;100&#x02009;&#x003bc;m.</p></caption><graphic xlink:href="41598_2018_34054_Fig6_HTML" id="d29e1082"/></fig></p><p id="Par11">Next, we investigated the role of IL-17C in development of airway eosinophilia induced by inhalation of papain, which is a papaya&#x02013;derived cysteine and a homologue to house dust mite-derived Der p1 and human cathepsin B<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. That eosinophilia induction is mediated by IL-33-stimulated ILC2s and basophils, but not T cells<sup><xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref></sup>. After papain inhalation, airway eosinophilia was assessed by the eosinophil count in BAL fluids and was similar in both <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a</xref>). The degree of pulmonary inflammation, based on histological analysis (HE and PAS staining, respectively), was also equivalent in the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice during papain-induced airway eosinophilia (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7b,c</xref>). These observations suggest that IL-17C is not essential for induction of ILC2- and basophil-mediated papain-induced airway eosinophilia.<fig id="Fig7"><label>Figure 7</label><caption><p>Normal development of T cell-independent airway eosinophilia in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. Mice were treated intratracheally with papain or heat-inactivated papain (HIP). 24&#x02009;hours after the last challenge, bronchoalveolar lavage (BAL) fluids and the lungs were collected. (<bold>a</bold>) Cell counts in BAL fluids. Wild-type mice (HIP, n&#x02009;=&#x02009;10; Papain, n&#x02009;=&#x02009;21) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (HIP, n&#x02009;=&#x02009;10; Papain, n&#x02009;=&#x02009;21). The data show the mean&#x02009;+&#x02009;SEM. **p&#x02009;&#x0003c;&#x02009;0.01 and ***p&#x02009;&#x0003c;&#x02009;0.001. (<bold>b</bold>,<bold>c</bold>) Representative images of lung sections stained with hematoxylin and eosin (<bold>b</bold>) and PAS (<bold>c</bold>). Bars&#x02009;=&#x02009;50&#x02009;&#x003bc;m.</p></caption><graphic xlink:href="41598_2018_34054_Fig7_HTML" id="d29e1147"/></fig></p><p id="Par12">Inhalation of LPS in mice resulted in induction of neutrophil-dominant airway inflammation<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. In addition, LPS-induced airway neutrophilia developed normally in <italic>Rag1</italic><sup>&#x02212;/&#x02212;</sup> mice and <italic>Il17a</italic><sup>&#x02212;/&#x02212;</sup> mice<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, indicating that it is T cell- and IL-17A-independent. We found that T cell- and IL-17A-independent LPS-induced airway neutrophilia was similar in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice compared with wild-type mice (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8a</xref>). The levels of IL-6, IL-1&#x003b2; and TNF in the BAL fluids were also comparable between <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and wild-type mice after LPS inhalation (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8b</xref>). Although the levels of IL-17A in the BAL fluids were significantly increased in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice compared with wild-type mice (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8b</xref>), these observations indicate that IL-17C is not essential for T cell- and IL-17A-independent LPS-induced airway neutrophilia.<fig id="Fig8"><label>Figure 8</label><caption><p>Normal development of T cell- and IL-17A-independent airway neutrophilia in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. Mice were treated intratracheally with LPS or saline. 24&#x02009;hours later, bronchoalveolar lavage (BAL) fluids were collected. (<bold>a</bold>)Cell counts in BAL fluids. Wild-type mice (saline, n&#x02009;=&#x02009;5; LPS, n&#x02009;=&#x02009;10) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (LPS, n&#x02009;=&#x02009;5). (<bold>b</bold>) The levels of cytokines in the BAL fluids in (<bold>a</bold>). The data show the mean&#x02009;+&#x02009;SEM. ***p&#x02009;&#x0003c;&#x02009;0.001 vs. wild-type mice.</p></caption><graphic xlink:href="41598_2018_34054_Fig8_HTML" id="d29e1222"/></fig></p></sec><sec id="Sec8"><title>IL-17C is involved in induction of endotoxin shock</title><p id="Par13"><italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> mice were more highly susceptible to LPS-induced endotoxin shock than wild-type mice, suggesting that T cells, B cells and/or NKT cells play suppressive roles in the setting<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. In addition, looking at other members of the IL-17 cytokine family, IL-17A, but not IL-17F or IL-25, was important for LPS-induced endotoxin shock in mice<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. However, the contribution of IL-17C to the response remains unclear. We found that the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice were more resistant to endotoxin shock after intraperitoneal LPS injection compared with the wild-type mice (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9a</xref>). The levels of IL-17C were increased in peritoneal lavage fluids from the wild-type mice, but not the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice, at 3 and 6&#x02009;hours after intraperitoneal LPS injection (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9b</xref>). On the other hand, the levels of IL-17A, IL-6, IL-1&#x003b2;, TNF, KC and/or MIP2 were similarly increased in peritoneal lavage fluids of both groups and/or in sera (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9b</xref> and data not shown), suggesting that the effect of IL-17C on LPS-induced endotoxin shock is independent of those cytokines. In addition, the number of inflammatory cells and levels of IL-1&#x003b2;, IL-6, TNF, KC and MIP-2 in the BAL fluids were also identical between both groups in the setting (data not shown).<fig id="Fig9"><label>Figure 9</label><caption><p>Strong resistance of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice to T cell-independent endotoxin shock. Female mice were injected intraperitoneally with LPS. After LPS injection, survival was monitored, and peritoneal fluids were collected at the indicated points. (<bold>a</bold>) Survival of wild-type (n&#x02009;=&#x02009;47) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> (n&#x02009;=&#x02009;46) mice after LPS injection. ***p&#x02009;&#x0003c;&#x02009;0.001. (<bold>b</bold>) The concentrations of IL-17C, IL-1&#x003b2;, IL-6, IL-17A and TNF in peritoneal lavage fluids from wild-type mice (0&#x02009;h, n&#x02009;=&#x02009;5; 3&#x02009;h, n&#x02009;=&#x02009;5; 6&#x02009;h, n&#x02009;=&#x02009;6) and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice (0&#x02009;h, n&#x02009;=&#x02009;5; 3&#x02009;h, n&#x02009;=&#x02009;5; 6&#x02009;h, n&#x02009;=&#x02009;6) were measured by ELISA. The data show the mean&#x02009;+&#x02009;SEM. *p&#x02009;&#x0003c;&#x02009;0.05: wild-type mice vs. <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. (<bold>c</bold>) Peritoneal F4/80<sup>&#x02212;</sup> and F4/80<sup>+</sup> cells were stimulated with LPS for the indicated times. The expression levels of <italic>Il17c</italic> and <italic>Il17re</italic> mRNAs in the cells were determined by quantitative PCR. The data show the mean&#x02009;+&#x02009;SEM (n&#x02009;=&#x02009;3). (<bold>d</bold>) The expression levels of <italic>Il17c</italic>, <italic>Il17re</italic>, <italic>Il1b</italic>, <italic>Il6</italic>, <italic>Il17a</italic> and <italic>Tnfa</italic> mRNAs in the tissues and peritoneal lavage fluid cells from wild-type mice at 0, 3 and 6&#x02009;h after LPS injection were determined by quantitative PCR. The data show the mean&#x02009;+&#x02009;SEM (n&#x02009;=&#x02009;5). *p&#x02009;&#x0003c;&#x02009;0.05, **p&#x02009;&#x0003c;&#x02009;0.01 and ***p&#x02009;&#x0003c;&#x02009;0.001 vs 0&#x02009;h (<bold>c</bold>,<bold>d</bold>).</p></caption><graphic xlink:href="41598_2018_34054_Fig9_HTML" id="d29e1339"/></fig></p><p id="Par14">Next, we purified F4/80-negative and -positive cells from the peritoneal lavage fluid of na&#x000ef;ve wild-type mice and cultured them in the presence and absence of LPS. After LPS stimulation, the expression levels of <italic>Il17c</italic> and <italic>Il17re</italic> mRNAs were significantly increased in F4/80<sup>+</sup> cells but hardly detectable in F4/80-negative cells (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9c</xref>). However, the level of IL-17C protein in the culture supernatants of F4/80<sup>+</sup> cells was below the limit of detection by ELISA (data not shown). In addition, the expression levels of <italic>Il17c</italic> mRNA were increased in the duodenum, jejunum, ileum and colon, but barely detectable in the peritoneum and peritoneal lavage fluid cells, of wild-type mice after LPS injection (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8d</xref>). On the other hand, <italic>Il17re</italic> mRNA was constitutively expressed in those tissues/cells, but its level decreased after LPS injection (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9d</xref>). In contrast to <italic>Il17c</italic> mRNA, expression of mRNA for each of <italic>Il1b</italic>, <italic>Il6</italic>, <italic>Tnfa and Il17a</italic> was increased in peritoneal lavage fluid cells from wild-type mice after LPS injection (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9d</xref>).</p><p id="Par15">To elucidate the contribution of macrophage-derived IL-17C to macrophage activation, we cultured M-CSF-induced bone marrow cell-derived macrophages (BMM&#x003d5;) from wild-type and <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice in the presence of LPS. The levels of IL-1&#x003b2;, IL-6 and TNF in the culture supernatants were similar between the two cell populations in the setting (data not shown). In addition, when peritoneal F4/80<sup>+</sup> cells of wild-type mice were stimulated with LPS in the presence of recombinant IL-17C, LPS-mediated IL-1&#x003b2;, IL-6 and TNF productions were not affected (data not shown). These observations suggest that cells of the gut other than peritoneal F4/80<sup>+</sup> cells are producers of and responders to IL-17C during LPS-induced endotoxin shock.</p></sec></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p id="Par16">IL-17C is preferentially produced by non-immune cells such as colonic and lung epithelial cells<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref></sup>, keratinocytes<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup> and smooth muscle cells<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, in mice and/or humans. It is known to enhance IL-17A production by Th17 cells, contributing to development of Th17 cell-mediated experimental autoimmune encephalomyelitis<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. In the present study, we used <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice to investigate the roles of IL-17C in T cell-dependent and -independent diseases.</p><p id="Par17">We demonstrated that <italic>Il17c</italic> mRNA was constitutively expressed in the skin of mice (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>), suggesting that IL-17C may be involved in host defense via the skin and/or in development of certain skin diseases. In support of that, <italic>Il17c</italic> mRNA was increased in inflamed skin from patients with psoriasis<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Moreover, <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Il17re</italic><sup>&#x02212;/&#x02212;</sup> mice showed decreased development of imiquimod-induced psoriatic dermatitis<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, which is mediated by IL-17-producing &#x003b3;&#x003b4; T cells and ILC3, but not Th17 cells<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par18">Since IL-17C can enhance IL-17A production by Th17 cells<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, we examined for involvement of IL-17C in development of allergic dermatitis, such as hapten-induced CHS, which is mediated by hapten-specific Th17 cells<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. Indeed, we found that <italic>Il17c</italic> mRNA expression was increased in the inflamed skin of wild-type mice during FITC- and DNFB-induced CHS (Figs&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>). Although mRNA expression for several cytokines and/or chemokines was reduced in the inflamed skin during FITC- and/or DNFB-induced CHS (Figs&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>), <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice showed normal development of FITC- or DNFB-induced CHS.</p><p id="Par19">We previously reported that <italic>Il17a</italic><sup>&#x02212;/&#x02212;</sup> mice showed impaired DNFB-induced CHS<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Although IL-17A-heterozygous (<italic>Il17a</italic><sup>+/&#x02212;</sup>) mice show half&#x02013;levels of IL-17A production compared with wild-type mice, the development of certain allergic diseases, including CHS, in <italic>Il17a</italic><sup>+/&#x02212;</sup> mice was similar to in wild-type mice. These observations suggest that even the apparently reduced levels of IL-17A are sufficient to fully induce the inflammation of CHS in <italic>Il17a</italic><sup>+/&#x02212;</sup> mice. We also found that <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice showed reduced hapten-specific IgG1 and IgG2a production during DNFB-induced CHS. However, it was reported that B cell-deficient mice showed normal development of DNFB-induced CHS<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. These observations suggest that although the deficiency of IL-17C resulted in reduced, but not completely abrogated, mRNA expression for certain cytokines and chemokines and Ab production, even the reduced mRNA levels may be sufficient for induction of inflammation. The levels of <italic>Il1b</italic> mRNA expression were comparable between the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice and wild-type mice during FITC- and DNFB-induced CHS (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a,b</xref>). On the other hand, the levels of <italic>Il1b</italic> mRNA expression were reduced in the vehicle-treated skin of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice compared with the wild-type mice during FITC-, but not DNFB-, induced CHS (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a,b</xref>). Those differences may have been caused by the different chemicals used to prepare the vehicles: FITC was dissolved in a mixture of dibutylphathalate and acetone, whereas DNFB was dissolved in a mixture of olive oil and acetone. Dibutylphathalate is known to be an irritant that can induce IL-1&#x003b2;-dependent activation of immune cells<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Therefore, although IL-17C seemed to be important for induction of <italic>Il1b</italic> mRNA expression in response to the irritant effect of dibutylphathalate, this cytokine is not essential for induction of <italic>Il1b</italic> mRNA expression in the elicitation phase of FITC-induced CHS. Thus, unlike the case of imiquimod-induced psoriatic dermatitis<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, IL-17C is not essential for development of FITC- or DNFB-induced CHS. These observations suggest that IL-17C may be involved in IL-17-producing &#x003b3;&#x003b4; T cell- and ILC3-mediated immune responses, rather than Th17 cell- and Tc17 cell-mediated immune responses, in the skin.</p><p id="Par20">Moreover, it is known that liver injury during Con A-induced hepatitis is mediated by Fas on Tc cells<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, and IL-17A is involved in the setting<sup><xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref></sup>. We demonstrated that Con A-induced hepatitis developed normally in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice, indicating that IL-17C is not essential for that development (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). It was recently reported that Con A-induced hepatitis was milder in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. However, even when we used those authors&#x02019; experimental protocol, we found that Con A-induced hepatitis developed similarly in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice to in wild-type mice (data not shown). A similar discrepancy was also observed in <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice during <italic>Candida albicans</italic> infection: Conti <italic>et al</italic>. reported that IL-17C was dispensable for host defense against <italic>Candida albicans</italic><sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, whereas Huang <italic>et al</italic>. reported that IL-17C was important for that defense<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p><p id="Par21">The <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice in the paper by Huang <italic>et al</italic>. were originally generated by using 129/TC1 ES cells, as they previously described<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. In that earlier report<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, the authors used C57BL/6 mice obtained from Jackson Laboratories. Although they did not describe how many times the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice on the 129/TC1 background were backcrossed with &#x0201c;C57BL/6J mice&#x0201d;, we presume that their mice must be on the &#x0201c;C57BL/6J background&#x0201d;. On the other hand, our <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice were generated by using C57BL/6 ES cells and are on the &#x0201c;C57BL/6N&#x0201d; background. The susceptibility of mice to Con A-induced hepatitis was reported to be affected by their genetic background<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. In addition, the intestinal microbiota, which affect immune responses, are different between C57BL/6J and C57BL/6N mice<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Moreover, susceptibility to Con A-induced hepatitis is influenced by the intestinal microbiota<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. The apparent discrepancy between their and our results may be due to the different genetic backgrounds and/or housing environments of the mice.</p><p id="Par22"><italic>Il17c</italic> mRNA was constitutively expressed in the lungs of mice (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>), and lung epithelial cells are known to produce IL-17C, suggesting that IL-17C may be involved in host defense via the lungs and/or in development of certain pulmonary diseases such as COPD and cystic fibrosis<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. <italic>Il17a</italic><sup>&#x02212;/&#x02212;</sup> mice showed reduced bleomycin-induced pulmonary fibrosis<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, and it was suggested that Th17 cell- and &#x003b3;&#x003b4; T cell-, but not iNKT cell-, derived IL-17A is important in those settings<sup><xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref></sup>. However, since bleomycin-induced pulmonary fibrosis is known to develop normally in T/B cell-deficient <italic>scid/scid</italic> mice<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, IL-17A produced by non-immune/immune cells other than T cells may be crucial for that. Thus, it was not essential for development of bleomycin-induced pulmonary fibrosis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>), although we expected IL-17C to contribute to development of T cell-independent IL-17A-mediated bleomycin-induced pulmonary fibrosis.</p><p id="Par23">Like IL-17A, IL-17C is known to be involved in recruitment of neutrophils into local inflammatory sites<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Indeed, it was shown that IL-17A-mediated IL-17C expression by alveolar epithelial cells is important for recruitment of neutrophils by inducing IL-6 and neutrophil chemoattractants such as KC and MIP-2 in the lungs during <italic>Pseudomonas aeruginosa</italic> infection<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. In contrast, we found that IL-17C is not essential for recruitment of neutrophils or production of cytokines (IL-1&#x003b2;, IL-6 and TNF) and chemokines (KC and MIP-2) in the lungs of mice after LPS inhalation (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). Airway neutrophilia during <italic>Pseudomonas aeruginosa</italic> infection is dependent on IL-17A<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, which is produced at least in part by Th17 cells<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, whereas LPS-induced airway neutrophilia is independent of IL-17A and T cells<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Thus, IL-17C may be important for IL-17A-dependent, but not -independent, airway neutrophilia.</p><p id="Par24"><italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> mice were highly susceptible, but <italic>Il17a</italic><sup>&#x02212;/&#x02212;</sup> mice were resistant, to LPS-induced endotoxin shock compared with wild-type mice<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, suggesting that IL-17A produced by other non-immune/immune cells besides T and NKT cells is crucial for protection against LPS-induced endotoxin shock. Like <italic>Il17a</italic><sup>&#x02212;/&#x02212;</sup> mice<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, we found that <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice were resistant to T cell-independent IL-17A-mediated LPS-induced endotoxin shock, without any effect on production of IL-17A as well as other proinflammatory cytokines such as IL-1&#x003b2;, IL-6 and TNF (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>). Those findings suggest that IL-17C is crucial for protection against LPS-induced endotoxin shock, independently of IL-17A, IL-1&#x003b2;, IL-6 and TNF.</p><p id="Par25">Taken all together, our observations indicate that IL-17C is not essential for development of T cell-dependent FITC- or DNFB-induced CHS or Con A-induced hepatitis. On the other hand, IL-17C is important for development of T cell-independent DSS-induced colitis and LPS-induced endotoxin shock, but not for bleomycin-induced pulmonary fibrosis, papain-induced airway eosinophilia or LPS-induced airway neutrophilia.</p></sec><sec id="Sec10"><title>Methods</title><sec id="Sec11"><title>Mice</title><p id="Par26">C57BL/6N wild-type mice were obtained from Japan SLC, Inc. <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice on the C57BL/6N background were generated as follows. The <italic>Il17</italic> gene was disrupted by replacement of the region from exon 1 to exon 3 with a neomycin resistance gene, flanked by <italic>loxP</italic> sequences (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Homologous regions were amplified by PCR using the following primers: 5&#x02032;-AGTAACAACAGATACACCGCCACC-3&#x02032; and 5&#x02032;-AACAGGTGAAGCCTGGCTGTGTGC-3&#x02032; to generate a 8-kb fragment, and 5&#x02032;-TCCAGGACAGACATTCCAGGCACC-3&#x02032; and 5&#x02032;-TAGGGACAGTAAGCAGCTTCAACC-3&#x02032; to generate a 1.5-kb fragment. The targeting vector was electroporated into C57BL/6N ES cells (EGR-101, kindly provided by Dr. Masaru Okabe, Osaka University). Male chimeric mice were obtained from two distinct targeted clones and mated with C57BL/6N female mice. Genotyping of <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice was performed by PCR using the following primers: common (5&#x02032;-CACAAGGCAAAGGCTGGGCATAGC-3&#x02032;), WT (5&#x02032;-CCAGCCCACCGAGCTCCGAGCTGC-3&#x02032;) and MT (5&#x02032;-GGAAGACAATAGCAGGCATGCTGG-3&#x02032;). The common and WT primers were used for detection of wild-type alleles (~510&#x02009;bp), and the common and MT primers were used for detection of mutant alleles (~270&#x02009;bp). All mice were housed in a specific-pathogen-free environment at The Institute of Medical Science, The University of Tokyo. The animal protocols for experiments were approved by the Institutional Review Board of the Institute (A11-28 and A14-10), and all experiments were conducted according to the ethical and safety guidelines of the Institute.</p></sec><sec id="Sec12"><title>Quantitative PCR</title><p id="Par27">Total RNA was prepared from tissues using Sepasol (Nacalai Tesque, Inc.) and treated with DNase (TURBO DNA-free-kit; Thermo Fisher Scientific Inc.). cDNA was synthesized from the isolated RNA by RT-PCR (PrimeScript RT Reagent kit; TAKARA BIO Inc.) or ReverTra Ace qPCR (RT Master Mix with gDNA; TOYOBO CO.). Quantitative real-time PCR was performed with SYBER Premix Ex Taq (TAKARA BIO Inc.) or THUNDERBIRD SYBR qPCR Mix (TOYOBO CO.) using a CFX384<sup>TM</sup> Touch Real-time PCR Detection System (BioRad Laboratories, Inc.). Relative gene expression was determined against the expression levels of 18s rRNA (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>) and <italic>Gapdh</italic> mRNA (other experiments). The designed primers are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sequences of primers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Forward (5&#x02032;&#x02013;3&#x02032;)</th><th>Reverse (5&#x02032;&#x02013;3&#x02032;)</th></tr></thead><tbody><tr><td>
<italic>Ccl11</italic>
</td><td>GAATCACCAACAACAGATGCAC</td><td>ATCCTGGACCCACTTCTTCTT</td></tr><tr><td>
<italic>Ccl17</italic>
</td><td>AGGAAGTTGGTGAGCTGGTATAAG</td><td>TCTTCACATGTTTGTCTTTGGG</td></tr><tr><td>
<italic>Ccl20</italic>
</td><td>GAGCTATTGTGGGTTTCACAAGAC</td><td>ACTCTTAGGCTGAGGAGGTTCAC</td></tr><tr><td>
<italic>Ccl22</italic>
</td><td>AGGTCCCTATGGTGCCAATGT</td><td>CGGCAGGATTTTGAGGTCCA</td></tr><tr><td>
<italic>Cxcl10</italic>
</td><td>CCAAGTGCTGCCGTCATTTTC</td><td>GGCTCGCAGGGATGATTTCAA</td></tr><tr><td>
<italic>Ifng</italic>
</td><td>GAACTGGCAAAAGGATGGTGA</td><td>TGTGGGTTGTTGACCTCAAAC</td></tr><tr><td>
<italic>Il1b</italic>
</td><td>CAACCAACAAGTGATATTCTCCATG</td><td>GATCCACACTCTCCAGCTGCA</td></tr><tr><td>
<italic>Il4</italic>
</td><td>TCCAAGGTGCTTCGCATATTTT</td><td>CAGCTTATCGATGAATCCAGGC</td></tr><tr><td>
<italic>Il6</italic>
</td><td>GAGGATACCACTCCCAACAGACC</td><td>AAGTGCATCATCGTTGTTCATACA</td></tr><tr><td>
<italic>Il13</italic>
</td><td>GGCAGCAGCTTGAGCACATT</td><td>GGCATAGGCAGCAAACCATG</td></tr><tr><td>
<italic>Il17a</italic>
</td><td>CCGCAATGAAGACCCTGATAGAT</td><td>AGAATTCATGTGGTGGTCCAGC</td></tr><tr><td>
<italic>Il17c</italic>
</td><td>CTGGAAGCTGACACTCACG</td><td>GGTAGCGGTTCTCATCTGTG</td></tr><tr><td>
<italic>Il17re</italic>
</td><td>CAGTCCCAGTGACGCTAGAC</td><td>ACCCACTAGAGCGGTGAGAG</td></tr><tr><td>
<italic>Tnfa</italic>
</td><td>GCCTCCCTCTCATCAGTTCT</td><td>CACTTGGTGGTTTGCTACGA</td></tr><tr><td>
<italic>Gapdh</italic>
</td><td>CCCACTCTTCCACCTTCGATG</td><td>AGGTCCACCACCCTGTTGCT</td></tr><tr><td>18s rRNA</td><td>GTAACCCGTTGAACCCCATT</td><td>CCATCCAATCGGTAGTAGCG</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec13"><title>Dextran sodium sulfate (DSS)-induced colitis</title><p id="Par28">Mice were provided sterile drinking water containing 2% DSS (MW&#x02009;=&#x02009;36,000-50,000; MP Biomedicals) ad libitum for 5 days, followed by 15 days of plain drinking water<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Each animal&#x02019;s body weight was monitored daily. Histological scores were determined as described elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p></sec><sec id="Sec14"><title>Contact hypersensitivity (CHS)</title><p id="Par29">FITC- and DNFB-induced CHS and measurement of FITC-specific and DNP-specific serum Igs were performed as described elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p></sec><sec id="Sec15"><title>Bleomycin-induced pulmonary fibrosis</title><p id="Par30">Mice were treated intratracheally with 2&#x02009;mg/kg bleomycin (NIPPON KAYAKU CO.) or an equal volume of PBS as a control. Fourteen days later, bronchoalveolar lavage (BAL) fluids were collected. The total cell counts and leukocyte profiles were determined with a hemocytometer (XT-1800i; Sysmex), as described previously<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p></sec><sec id="Sec16"><title>Papain-induced airway inflammation</title><p id="Par31">Papain-induced airway inflammation was generated as described elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. Twenty-four hours after the last inhalation of papain, BAL fluids were collected, and the total cell counts and leukocyte profiles were determined with a hemocytometer (XT-1800i; Sysmex), as above.</p></sec><sec id="Sec17"><title>LPS-induced airway inflammation</title><p id="Par32">LPS-induced airway inflammation was established as described elsewhere<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. In brief, mice were treated intratracheally with 20&#x02009;&#x003bc;l of 0.5&#x02009;mg/ml LPS (<italic>Escherichia coli</italic> serotype 0111:B4; Sigma&#x02013;Aldrich) or an equal volume of saline as a control. Twenty-four hours after the last inhalation of LPS or saline, BAL fluids were collected, and the total cell counts and leukocyte profiles were determined as described above.</p></sec><sec id="Sec18"><title>Concanavalin A (Con A)-induced hepatitis</title><p id="Par33">Con A-induced hepatitis was generated as described elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Fourteen hours after the injection of Con A, sera were collected, and the levels of GOT and GPT in the sera were determined using Transaminase CII-test Wako (Wako).</p></sec><sec id="Sec19"><title>LPS-induced endotoxin shock</title><p id="Par34">Mice were intraperitoneally injected with 15&#x02009;mg/kg of LPS (<italic>Escherichia coli</italic> serotype 0111:B4; Sigma&#x02013;Aldrich) as described elsewhere<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. After LPS injection, the survival of the mice was monitored. Peritoneal cells and fluids were collected at 0, 3 and 6&#x02009;hours after LPS injection, as described elsewhere<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p></sec><sec id="Sec20"><title>ELISA for cytokines</title><p id="Par35">The concentrations of IL-1&#x003b2;, IL-6, IL-17A, TNF, KC and MIP-2 were determined using ELISA kits (eBioscience, Biolegend or PeproTech), according to the manufacturers&#x02019; instructions. For IL-17C detection, plates (Nunc) for ELISA were coated with rat anti-mouse IL-17C mAb (MAB2306; R&#x00026;D Systems; 2&#x02009;&#x003bc;g/ml in PBS) as a capture Ab at room temperature overnight. After blocking with 1x Assay Diluent (BioLegend), samples and recombinant mouse IL-17C (R&#x00026;D Systems) as a standard cytokine were applied to the wells, and the plates were incubated at 4&#x02009;&#x000b0;C overnight. After washing the wells, goat anti-mouse IL-17C polyclonal Ab (AF2306; R&#x00026;D Systems; 1.6&#x02009;&#x003bc;g/ml in 1x Assay Diluent), as a detection Ab, was applied to the wells, followed by incubation at room temperature for 1&#x02009;hour. After washing the wells, HRP-conjugated donkey anti-goat IgG (V805A; Promega; 1&#x02009;&#x003bc;g/ml in 1x Assay Diluent) was added to the wells, followed by incubation at room temperature for 30&#x02009;min. Tetramethylbenzidine solution (Nacalai Tesque) was used as the substrate. The reaction was stopped by adding 0.17&#x02009;M sulfuric acid, and the OD450 was measured using a plate reader (VersaMax; Molecular Devices).</p></sec><sec id="Sec21"><title>Peritoneal cell culture</title><p id="Par36">Peritoneal lavage fluid cells were collected from na&#x000ef;ve wild-type mice. The cells were incubated with anti-CD16/CD32 mAb (93; eBioscience) in HBSS containing 2% FCS for 15&#x02009;min at 4&#x02009;&#x000b0;C, and then with biotinylated anti-mouse F4/80 mAb (BM8, BioLegend) for 25&#x02009;min at 4&#x02009;&#x000b0;C. After washing, the cells were incubated with streptavidin-beads (Miltenyi Biotec) for 15&#x02009;min at 4&#x02009;&#x000b0;C. After washing, F4/80-negative and -positive cells were separated using a MACS system (Miltenyi Biotec). The F4/80-negative and -positive cells were cultured in AIM V Medium (GIBCO) supplemented with AlbuMAX Supplement (GIBCO) in the presence of 2&#x02009;&#x003bc;g/ml LPS for 0, 3, 6, 12 and 24&#x02009;h at 37&#x02009;&#x000b0;C. The cells were collected, and the total RNA of the cells was prepared as described above.</p></sec><sec id="Sec22"><title>Histology</title><p id="Par37">Tissues were fixed in Carnoy&#x02019;s solution and embedded in paraffin. Then sections were prepared and stained using hematoxylin and eosin, periodic acid-Schiff (PAS) or Elastica van Gieson (EVG) staining methods.</p></sec><sec id="Sec23"><title>Statistics</title><p id="Par38">The Mann-Whitney U test, two-tailed (for quantitative PCR analysis), a Kaplan&#x02013;Meier method (for survival) and a two-tailed, unpaired Student&#x02019;s t-test (for other experiments) were applied to test for statistical significance using Graphpad Prism software (Graphpad Prism). P values of less than 0.05 were considered statistically significant.</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Masako Fujiwara and Yoshiko Shimamoto for their skilled technical assistance. We also thank Lawrence W. Stiver (Quality Translation Co., Ltd.; Tokyo, Japan; qualityt@gol.com) for his critical reading of the manuscript. This work was supported by Grants-in-Aid for Scientific Research (B) (S. Nakae) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (S. Nakae.).</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>S.Y., A.N. and S. Nakae designed the experiments. S.Y., A.N., T.N., T.Y., E.S., Y.H., K.A., S. Narushima and H.M. performed the experiments. A.N., S.Y., K.S. and S. Nakae generated the <italic>Il17c</italic><sup>&#x02212;/&#x02212;</sup> mice. K.M. and I.H. provided resources. S.Y., I.H. and S.N. wrote the manuscript. All authors reviewed the article.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p>The authors declare no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>773</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.2.773</pub-id><pub-id pub-id-type="pmid">10639155</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurst</surname><given-names>SD</given-names></name><etal/></person-group><article-title>New IL-17 family members promote Th1 or Th2 responses in the lung: <italic>in vivo</italic> function of the novel cytokine IL-25</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.169.1.443</pub-id><pub-id pub-id-type="pmid">12077275</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X</given-names></name><etal/></person-group><article-title>IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens</article-title><source>Nat Immunol</source><year>2011</year><volume>12</volume><fpage>1151</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1038/ni.2155</pub-id><pub-id pub-id-type="pmid">21993849</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez-Carrozzi</surname><given-names>V</given-names></name><etal/></person-group><article-title>IL-17C regulates the innate immune function of epithelial cells in an autocrine manner</article-title><source>Nat Immunol</source><year>2011</year><volume>12</volume><fpage>1159</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1038/ni.2156</pub-id><pub-id pub-id-type="pmid">21993848</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>E</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Rhee</surname><given-names>SH</given-names></name></person-group><article-title>Toll-like receptor 5 engagement induces interleukin-17C expression in intestinal epithelial cells</article-title><source>J Interferon Cytokine Res</source><year>2012</year><volume>32</volume><fpage>583</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1089/jir.2012.0053</pub-id><?supplied-pmid 22994872?><pub-id pub-id-type="pmid">22994872</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>P</given-names></name><etal/></person-group><article-title>IL-17C is a mediator of respiratory epithelial innate immune response</article-title><source>Am J Respir Cell Mol Biol</source><year>2013</year><volume>48</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2012-0232OC</pub-id><?supplied-pmid 23221046?><pub-id pub-id-type="pmid">23221046</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin</article-title><source>Br J Dermatol</source><year>2009</year><volume>160</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.2008.08902.x</pub-id><pub-id pub-id-type="pmid">19016708</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>C</given-names></name><name><surname>Riis</surname><given-names>JL</given-names></name><name><surname>Gedebjerg</surname><given-names>A</given-names></name><name><surname>Kragballe</surname><given-names>K</given-names></name><name><surname>Iversen</surname><given-names>L</given-names></name></person-group><article-title>Tumor necrosis factor alpha-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor kappaB</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>25487</fpage><lpage>25494</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.240671</pub-id><?supplied-pmid 21628458?><pub-id pub-id-type="pmid">21628458</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname><given-names>MJ</given-names></name><name><surname>Waseem</surname><given-names>TC</given-names></name><name><surname>Galkina</surname><given-names>EV</given-names></name></person-group><article-title>Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A&#x02009;+&#x02009;T Cells to the Aorta</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2016</year><volume>36</volume><fpage>1496</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307892</pub-id><?supplied-pmid 27365405?><pub-id pub-id-type="pmid">27365405</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>L</given-names></name><etal/></person-group><article-title>IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2016</year><volume>311</volume><fpage>L1015</fpage><lpage>L1022</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00158.2016</pub-id><?supplied-pmid 27694471?><pub-id pub-id-type="pmid">27694471</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>A</given-names></name><etal/></person-group><article-title>Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>2252</fpage><lpage>2262</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1201505</pub-id><?supplied-pmid 23359500?><pub-id pub-id-type="pmid">23359500</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedrich</surname><given-names>M</given-names></name><name><surname>Tillack</surname><given-names>C</given-names></name><name><surname>Wollenberg</surname><given-names>A</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name><name><surname>Brand</surname><given-names>S</given-names></name></person-group><article-title>IL-36g sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn&#x02019;s disease</article-title><source>Inflamm Bowel Dis</source><year>2014</year><volume>20</volume><fpage>1891</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1097/MIB.0000000000000198</pub-id><?supplied-pmid 25299544?><pub-id pub-id-type="pmid">25299544</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name></person-group><article-title>Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients</article-title><source>Mol Cells</source><year>2005</year><volume>19</volume><fpage>180</fpage><lpage>184</lpage><?supplied-pmid 15879699?><pub-id pub-id-type="pmid">15879699</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>7128</fpage><lpage>7136</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.10.7128</pub-id><pub-id pub-id-type="pmid">17982105</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>292</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1038/ng.553</pub-id><?supplied-pmid 20228798?><pub-id pub-id-type="pmid">20228798</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Regulation of intestinal inflammation and barrier function by IL-17C</article-title><source>J Immunol</source><year>2012</year><volume>189</volume><fpage>4226</fpage><lpage>4230</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1103014</pub-id><?supplied-pmid 23024280?><pub-id pub-id-type="pmid">23024280</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jungnickel</surname><given-names>C</given-names></name><etal/></person-group><article-title>IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth</article-title><source>Oncogene</source><year>2017</year><volume>36</volume><fpage>4182</fpage><lpage>4190</lpage><pub-id pub-id-type="doi">10.1038/onc.2017.28</pub-id><?supplied-pmid 28346430?><pub-id pub-id-type="pmid">28346430</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>R</given-names></name><etal/></person-group><article-title>High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma</article-title><source>J Exp Clin Cancer Res</source><year>2013</year><volume>32</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/1756-9966-32-3</pub-id><?supplied-pmid 23305119?><pub-id pub-id-type="pmid">23305119</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X</given-names></name><etal/></person-group><article-title>Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>140</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.11.018</pub-id><?supplied-pmid 24412611?><pub-id pub-id-type="pmid">24412611</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17receptor E</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>611</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.09.010</pub-id><?supplied-pmid 21982598?><pub-id pub-id-type="pmid">21982598</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwakura</surname><given-names>Y</given-names></name><name><surname>Nakae</surname><given-names>S</given-names></name><name><surname>Saijo</surname><given-names>S</given-names></name><name><surname>Ishigame</surname><given-names>H</given-names></name></person-group><article-title>The roles of IL-17A in inflammatory immune responses and host defense against pathogens</article-title><source>Immunol Rev</source><year>2008</year><volume>226</volume><fpage>57</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2008.00699.x</pub-id><pub-id pub-id-type="pmid">19161416</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seino</surname><given-names>K</given-names></name><etal/></person-group><article-title>Contribution of Fas ligand to T cell-mediated hepatic injury in mice</article-title><source>Gastroenterology</source><year>1997</year><volume>113</volume><fpage>1315</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1053/gast.1997.v113.pm9322527</pub-id><pub-id pub-id-type="pmid">9322527</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>LG</given-names></name><name><surname>Landstrom</surname><given-names>E</given-names></name><name><surname>Goldschmidt</surname><given-names>TJ</given-names></name><name><surname>Gronberg</surname><given-names>A</given-names></name><name><surname>Bylund-Fellenius</surname><given-names>AC</given-names></name></person-group><article-title>Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice</article-title><source>Inflamm Res</source><year>1996</year><volume>45</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1007/BF02285159</pub-id><pub-id pub-id-type="pmid">8741008</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippers</surname><given-names>A</given-names></name><etal/></person-group><article-title>b7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon</article-title><source>Mucosal Immunol</source><year>2016</year><volume>9</volume><fpage>527</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1038/mi.2015.82</pub-id><?supplied-pmid 26349655?><pub-id pub-id-type="pmid">26349655</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helene</surname><given-names>M</given-names></name><etal/></person-group><article-title>T cell independence of bleomycin-induced pulmonary fibrosis</article-title><source>J Leukoc Biol.</source><year>1999</year><volume>65</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1002/jlb.65.2.187</pub-id><pub-id pub-id-type="pmid">10088601</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases</article-title><source>J Exp Med</source><year>1988</year><volume>167</volume><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1084/jem.167.1.175</pub-id><pub-id pub-id-type="pmid">3335830</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oboki</surname><given-names>K</given-names></name><etal/></person-group><article-title>IL-33 is a crucial amplifier of innate rather than acquired immunity</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>18581</fpage><lpage>18586</lpage><pub-id pub-id-type="doi">10.1073/pnas.1003059107</pub-id><?supplied-pmid 20937871?><pub-id pub-id-type="pmid">20937871</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>TY</given-names></name><name><surname>Krauss</surname><given-names>RH</given-names></name><name><surname>Sun</surname><given-names>AC</given-names></name><name><surname>Takei</surname><given-names>F</given-names></name></person-group><article-title>Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation</article-title><source>Immunity</source><year>2012</year><volume>36</volume><fpage>451</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.020</pub-id><?supplied-pmid 22425247?><pub-id pub-id-type="pmid">22425247</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>758</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.04.013</pub-id><?supplied-pmid 24837103?><pub-id pub-id-type="pmid">24837103</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>H</given-names></name><etal/></person-group><article-title>An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers</article-title><source>Immunity</source><year>2015</year><volume>43</volume><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.021</pub-id><?supplied-pmid 26200013?><pub-id pub-id-type="pmid">26200013</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakae</surname><given-names>S</given-names></name><name><surname>Suto</surname><given-names>H</given-names></name><name><surname>Berry</surname><given-names>GJ</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>3640</fpage><lpage>3648</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-09-046128</pub-id><?supplied-pmid 17197430?><pub-id pub-id-type="pmid">17197430</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimura</surname><given-names>E</given-names></name><etal/></person-group><article-title>Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock</article-title><source>Biochem Biophys Res Commun</source><year>2014</year><volume>453</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.09.004</pub-id><?supplied-pmid 25204502?><pub-id pub-id-type="pmid">25204502</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantelyushin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Rorgammat&#x02009;+&#x02009;innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice</article-title><source>J Clin Invest</source><year>2012</year><volume>122</volume><fpage>2252</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1172/JCI61862</pub-id><?supplied-pmid 22546855?><pub-id pub-id-type="pmid">22546855</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakae</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses</article-title><source>Immunity</source><year>2002</year><volume>17</volume><fpage>375</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00391-6</pub-id><pub-id pub-id-type="pmid">12354389</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorbachev</surname><given-names>AV</given-names></name><name><surname>Fairchild</surname><given-names>RL</given-names></name></person-group><article-title>CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4&#x02009;+&#x02009;and CD8&#x02009;+&#x02009;T cells independently of IL-12</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>2443</fpage><lpage>2452</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.4.2443</pub-id><pub-id pub-id-type="pmid">15294958</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>KH</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Higashi</surname><given-names>N</given-names></name><name><surname>Irimura</surname><given-names>T</given-names></name></person-group><article-title>Migration of dermal cells expressing a macrophage C-type lectin during the sensitization phase of delayed-type hypersensitivity</article-title><source>J Leukoc Biol</source><year>2000</year><volume>68</volume><fpage>471</fpage><lpage>478</lpage><?supplied-pmid 11037967?><pub-id pub-id-type="pmid">11037967</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>KH</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Higashi</surname><given-names>N</given-names></name><name><surname>Irimura</surname><given-names>T</given-names></name></person-group><article-title>Involvement of cytokines in the skin-to-lymph node trafficking of cells of the monocyte-macrophage lineage expressing a C-type lectin</article-title><source>Int Immunol</source><year>2000</year><volume>12</volume><fpage>1695</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1093/intimm/12.12.1695</pub-id><pub-id pub-id-type="pmid">11099309</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Osteopontin regulates interleukin-17 production in hepatitis</article-title><source>Cytokine</source><year>2012</year><volume>60</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2012.06.287</pub-id><?supplied-pmid 22818182?><pub-id pub-id-type="pmid">22818182</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>T</given-names></name><etal/></person-group><article-title>Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>7473</fpage><lpage>7479</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.11.7473</pub-id><pub-id pub-id-type="pmid">19017936</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production</article-title><source>Eur J Immunol</source><year>2011</year><volume>41</volume><fpage>2828</fpage><lpage>2839</lpage><pub-id pub-id-type="doi">10.1002/eji.201141291</pub-id><?supplied-pmid 21953641?><pub-id pub-id-type="pmid">21953641</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis</article-title><source>J Immunol</source><year>2017</year><volume>198</volume><fpage>669</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600977</pub-id><?supplied-pmid 27956525?><pub-id pub-id-type="pmid">27956525</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>HR</given-names></name><etal/></person-group><article-title>Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0122807</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0122807</pub-id><?supplied-pmid 25849644?><pub-id pub-id-type="pmid">25849644</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>IL-17C is required for lethal inflammation during systemic fungal infection</article-title><source>Cell Mol Immunol</source><year>2016</year><volume>13</volume><fpage>474</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1038/cmi.2015.56</pub-id><pub-id pub-id-type="pmid">26166766</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Mice deficient in Vbeta8&#x02009;+&#x02009;NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction</article-title><source>Clin Exp Med</source><year>2007</year><volume>7</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1007/s10238-007-0122-2</pub-id><?supplied-pmid 17380303?><pub-id pub-id-type="pmid">17380303</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>II</given-names></name><etal/></person-group><article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title><source>Cell</source><year>2009</year><volume>139</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><?supplied-pmid 19836068?><pub-id pub-id-type="pmid">19836068</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajiya</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>386</volume><fpage>316</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.06.024</pub-id><?supplied-pmid 19523450?><pub-id pub-id-type="pmid">19523450</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Ran</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group><article-title>Intestinal microbiome and permeability in patients with autoimmune hepatitis</article-title><source>Best Pract Res Clin Gastroenterol</source><year>2017</year><volume>31</volume><fpage>669</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2017.09.013</pub-id><?supplied-pmid 29566910?><pub-id pub-id-type="pmid">29566910</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Bleomycin and IL-1b-mediated pulmonary fibrosis is IL-17A dependent</article-title><source>J Exp Med</source><year>2010</year><volume>207</volume><fpage>535</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1084/jem.20092121</pub-id><?supplied-pmid 20176803?><pub-id pub-id-type="pmid">20176803</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>RK</given-names></name><etal/></person-group><article-title>IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury</article-title><source>Inflammation</source><year>2008</year><volume>31</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1007/s10753-008-9062-6</pub-id><?supplied-pmid 18338242?><pub-id pub-id-type="pmid">18338242</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasse</surname><given-names>P</given-names></name><etal/></person-group><article-title>IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e23185</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0023185</pub-id><?supplied-pmid 21858022?><pub-id pub-id-type="pmid">21858022</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice</article-title><source>FEMS Immunol Med Microbiol</source><year>2011</year><volume>61</volume><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2010.00764.x</pub-id><?supplied-pmid 21204996?><pub-id pub-id-type="pmid">21204996</pub-id></element-citation></ref></ref-list></back></article>